ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kellanova (NYSE:K) Misses Q1 Revenue Estimates

K Cover Image

Packaged foods company Kellanova (NYSE: K) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $3.08 billion. Its non-GAAP profit of $0.90 per share was 11.1% below analysts’ consensus estimates.

Is now the time to buy Kellanova? Find out by accessing our full research report, it’s free.

Kellanova (K) Q1 CY2025 Highlights:

  • Revenue: $3.08 billion vs analyst estimates of $3.15 billion (3.7% year-on-year decline, 2% miss)
  • Adjusted EPS: $0.90 vs analyst expectations of $1.01 (11.1% miss)
  • Adjusted EBITDA: $522 million vs analyst estimates of $597.5 million (16.9% margin, 12.6% miss)
  • Operating Margin: 13.9%, up from 12.3% in the same quarter last year
  • Free Cash Flow was -$60 million, down from $209 million in the same quarter last year
  • Organic Revenue was flat year on year (5.4% in the same quarter last year)
  • Sales Volumes fell 2.5% year on year, in line with the same quarter last year
  • Market Capitalization: $28.57 billion

Company Overview

With Corn Flakes as its first and most iconic product, Kellanova (NYSE: K) is a packaged foods company that is dominant in the cereal and snack categories.

Sales Growth

A company’s long-term sales performance can indicate its overall quality. Any business can have short-term success, but a top-tier one grows for years.

With $12.63 billion in revenue over the past 12 months, Kellanova is one of the larger consumer staples companies and benefits from a well-known brand that influences purchasing decisions. However, its scale is a double-edged sword because there are only a finite number of major retail partners, placing a ceiling on its growth. For Kellanova to boost its sales, it likely needs to adjust its prices, launch new offerings, or lean into foreign markets.

As you can see below, Kellanova’s demand was weak over the last three years. Its sales fell by 2.6% annually as consumers bought less of its products.

Kellanova Quarterly Revenue

This quarter, Kellanova missed Wall Street’s estimates and reported a rather uninspiring 3.7% year-on-year revenue decline, generating $3.08 billion of revenue.

Looking ahead, sell-side analysts expect revenue to grow 2.2% over the next 12 months. While this projection implies its newer products will spur better top-line performance, it is still below the sector average.

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories.

Volume Growth

Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.

To analyze whether Kellanova generated its growth from changes in price or volume, we can compare its volume growth to its organic revenue growth, which excludes non-fundamental impacts on company financials like mergers and currency fluctuations.

Over the last two years, Kellanova’s average quarterly sales volumes have shrunk by 2.9%. This decrease isn’t ideal as the quantity demanded for consumer staples products is typically stable. Luckily, Kellanova was able to offset fewer customers purchasing its products by charging higher prices, enabling it to generate 5.1% average organic revenue growth. We hope the company can grow its volumes soon, however, as consistent price increases (on top of inflation) aren’t sustainable over the long term unless the business is really really special.

Kellanova Year-On-Year Volume Growth

In Kellanova’s Q1 2025, sales volumes dropped 2.5% year on year. This result represents a further deceleration from its historical levels, showing the business is struggling to move its products.

Key Takeaways from Kellanova’s Q1 Results

We struggled to find many positives in these results as its revenue, EPS, and EBITDA missed. Overall, this was a softer quarter. The stock remained flat at $82.80 immediately following the results.

Should you buy the stock or not? We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.